{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to compare the 3\u2010year recurrence rates of diabetic foot ulcers (DFU) and the rate of endovascular reintervention for chronic limb\u2010threatening ischaemia (CLTI) to recurrence rates of advanced\u2010stage cancers."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "We systematically collected original data reporting 3\u2010year DFU recurrence from studies published through 2024 and calculated a pooled mean."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The pooled 3\u2010year DFU recurrence rate was 58%, while the CLTI reintervention rate was 50%\u2014comparable to cancer recurrence rates: breast (25%\u201340%), prostate (30%\u201340%), colorectal (30%\u201350%), and lung (60%\u201380%)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 5,
    "max_score": 25
  },
  "model": "gpt-4o"
}